首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1630723

医疗植入市场规模、份额、成长分析，按产品类型、按材料类型、按地区 - 产业预测，2025 年至 2032 年

Medical Implants Market Size, Share, Growth Analysis, By Product Type (Orthopedic Implants, Cardiovascular Implants), By Biomaterial Type (Metallic Biomaterials, Ceramic Biomaterials), By Region - Industry Forecast 2025-2032

出版日期: 2025年01月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2023 年全球医疗植入市场规模将达到 964.4 亿美元，从 2024 年的 1030 亿美元增长到 2032 年的 1743.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.8%。

全球医疗植入市场包括用于替代或支持生物结构的植入式设备和组织，由于慢性病的增加和人口老化而发生了重大变化。随着越来越多的患者寻求治疗整形外科、心血管和神经系统疾病，对创新植入式解决方案的需求也日益增长。技术进步和微创手术技术进一步推动了市场成长。然而，挑战依然存在，包括高昂的手术费用、有限的保险覆盖、严格的法规以及感染疾病和植入失败等併发症。儘管存在这些障碍，但3D列印、生物相容性材料和数位医疗整合等创新仍然充满机会，为客製化植入和改善患者治疗效果铺平了道路。持续的研究和创新对于克服现有的挑战和增加市场潜力至关重要。

市场概况
整形外科植入
- 重组关节关节重建
- 膝关节置换移植
- 髋关节置换植入术
- 肢体
- 生物性骨材
- 创伤与颅颚颜面
心血管植入
- 起搏器
- 心臟再同步治疗设备 (CRT)
- CRT-P（含心律调节器功能的CRT）
- CRT-D（含心律调节器和ICD功能的CRT）
- 植入式心臟整流去颤器(ICD)
- 经静脉植入式心臟整流去颤器(T-ICD)
- 植入式心臟整流去颤器(S-ICD)
- 植入式心臟心律调节器(ICP)
支架
- 冠状动脉支架
- 药物释放型支架 (DES)
- 裸金属冠状动脉支架
- 生物可吸收支架
- 外周支架
- 髂骨
- 股骨-腘窝
- 肾
- 颈动脉
- 支架相关植入
- 合成移植物
- 腔静脉过滤器
结构性心臟植入
- 人工心臟瓣膜
- 植入式辅助人工心臟
- LVAD
- RVAD
- BIVAD
脊椎移植
- 脊椎固定移植
- 脊椎刺激器
- 脊椎压迫性骨折(VCF) 装置
- 运动保存装置/非融合装置
神经刺激设备
- 深部脑部刺激（DBS）
- 荐椎神经刺激（SNS）
- 迷走神经刺激（VNS）
- 脊髓刺激（SCS）
- 其他神经刺激设备
眼科植入
- 人工水晶体
- 青光眼植入
人工植牙
- 板式人工植牙
- 根型人工植牙
脸部植入
乳房植入

医疗植入市场规模（依材料类型）

市场概况
金属生医材料
陶瓷生医材料
高分子生医材料
天然生医材料

医疗植入市场规模

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较（2022-2024 年）

主要企业简介

Medtronic plc（Ireland）
Johnson & Johnson（United States）
Abbott Laboratories（United States）
Stryker Corporation（United States）
Boston Scientific Corporation（United States）
Zimmer Biomet Holdings, Inc.（United States）
Smith & Nephew plc（United Kingdom）
Edwards Lifesciences Corporation（United States）
Globus Medical, Inc.（United States）
Integra LifeSciences Holdings Corporation（United States）
Orthofix Medical Inc.（United States）
LivaNova PLC（United Kingdom）
Penumbra, Inc.（United States）
Glaukos Corporation（United States）
Nevro Corp.（United States）
Axogen, Inc.（United States）
SI-BONE, Inc.（United States）

结论和建议

简介目录

Product Code: SQMIG35H2125

Global Medical Implants Market size was valued at USD 96.44 billion in 2023 and is poised to grow from USD 103.0 billion in 2024 to USD 174.34 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The global medical implants market, which includes devices and tissues implanted to replace or support biological structures, is evolving significantly due to rising chronic conditions and an aging population. As patients increasingly seek relief from orthopedic, cardiovascular, and neurological disorders, the demand for innovative implantable solutions is on the rise. Market growth is further propelled by technological advancements and minimally invasive surgical techniques. However, challenges persist, including high procedure costs, limited insurance coverage, stringent regulations, and complications like infections and implant failures. Despite these hurdles, opportunities abound with innovations such as 3D printing, biocompatible materials, and digital healthcare integration, paving the way for customized implants and improved patient outcomes. Continuous research and innovation are crucial for overcoming existing challenges and enhancing market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Implants Market Segmental Analysis

Global Medical Implants Market is segmented by Product Type, Biomaterial Type and region. Based on Product Type, the market is segmented into Orthopedic Implants, Cardiovascular Implants, Stents, Structural Cardiac Implants, Spinal Implants, Neurostimulators, Opthalmic Implants, Dental Implants, Facial Implants and Breast Implants. Based on Biomaterial Type, the market is segmented into Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials and Natural Biomaterials. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Medical Implants Market

The growth of the global medical implants market is significantly propelled by remarkable technological advancements. For instance, the launch of robotic-assisted surgical systems for joint replacement in 2022 has revolutionized surgical precision, leading to reduced recovery periods and enhanced patient outcomes. These innovations not only optimize complex implant surgeries but also capture the interest of both patients and healthcare providers alike. As technology progresses, it continues to broaden the horizons for various implant procedures, solidifying the market's expansion and further augmenting confidence in the efficacy of medical implants across the healthcare landscape.

Restraints in the Global Medical Implants Market

One of the primary restraints affecting the Global Medical Implants market is the high cost associated with these devices. The expenses related to implant materials, surgical interventions, and post-operative care can pose significant barriers to patient access, especially in areas with restricted healthcare infrastructure or insufficient insurance benefits. This challenge surrounding the affordability of medical implants continues to impede their broader acceptance and utilization, ultimately constraining market expansion. As a result, the financial burden of medical implants remains a critical factor that must be addressed to enhance accessibility and support growth within the industry.

Market Trends of the Global Medical Implants Market

The Global Medical Implants market is increasingly influenced by the rising trend of minimally invasive procedures, which gained momentum in 2022. Techniques like laparoscopy and arthroscopy are redefining surgical approaches by providing significant advantages, including smaller incisions, minimal scarring, faster recovery, and lowered risk of postoperative complications. This growing preference for less invasive techniques has spurred innovation in specialized implants and instrumentation, allowing for tailored, patient-centric treatment options. As healthcare professionals and patients continue to prioritize enhanced safety and efficiency, the market for medical implants is expected to expand, aligning with advancements in procedures and technologies that emphasize minimally invasive solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Medical Implants Market Size by Product Type & CAGR (2025-2032)

Market Overview
Orthopedic Implants
- Reconstructive Joint Replacements
- Knee Replacement Implants
- Hip Replacement Implants
- Extremities
- Orthobiologics
- Trauma & Craniomaxillofacial
Cardiovascular Implants
- Pacing Devices
- Cardiac Resynchronization Therapy Devices (CRTs)
- CRT-P (CRT with pacemaker function)
- CRT-D (CRT with pacemaker and ICD function)
- Implantable Cardioverter Defibrillators (ICDs)
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Implantable Cardioc Pacemakers (ICPs)
Stents
- Coronary stents
- Drug-eluting Stents (DES)
- Bare-metal Coronary Stents
- Bioabsorbable Stents
- Peripheral stents
- Iliac
- Femoral-Popliteal
- Renal
- Carotid
- Stent-related Implants
- Synthetic Grafts
- Vena Cava Filters
Structural Cardiac Implants
- Mechanical Heart Valves
- Implantable Ventricular-assist Devices
- LVAD
- RVAD
- BIVAD
Spinal Implants
- Spinal fusion implants
- Spinal bone stimulators
- Vertebral Compression Fracture (VCF) Devices
- Motion Preservation Devices/Non-Fusion Devices
Neurostimulators
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Spinal Cord Stimulation (SCS)
- Other neurostimulators
Opthalmic Implants
- Intraocular Lens
- Glaucoma Implants
Dental Implants
- Plate Form Dental Implants
- Root Form Dental Implants
Facial Implants
Breast Implants

Global Medical Implants Market Size by Biomaterial Type & CAGR (2025-2032)

Market Overview
Metallic Biomaterials
Ceramic Biomaterials
Polymers Biomaterials
Natural Biomaterials

Global Medical Implants Market Size & CAGR (2025-2032)

North America (Product Type, Biomaterial Type)
- US
- Canada
Europe (Product Type, Biomaterial Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Biomaterial Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Biomaterial Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Biomaterial Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Globus Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glaukos Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axogen, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SI-BONE, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments